CLINICAL_TRIALS
trial_result
· 2022-07-19
Clinical Trial Update: Response of Children With Atopic Dermatitis (Eczema) to Eucrisa [Phase 4]
Summary
Phase 4 trial update evaluating response of children with atopic dermatitis (eczema) to Eucrisa.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Atopic Dermatitis, Eczema | Phase 4 | Status: COMPLETED